What is Earnings Per Share (EPS)?

Earnings per share (EPS) is calculated by dividing a company's net income by its weighted average number of diluted shares outstanding. It tells investors how much profit is attributable to each share of stock and is one of the most fundamental measures of corporate profitability. EPS is reported quarterly and annually, and analysts closely track both reported (GAAP) and adjusted (non-GAAP) EPS figures.

The two main variants are basic EPS and diluted EPS. Basic EPS uses the actual number of shares outstanding, while diluted EPS includes the potential impact of stock options, convertible bonds, and warrants that could increase the share count. Diluted EPS is generally considered the more conservative and realistic measure, especially for cannabis companies that frequently use equity-linked instruments to raise capital.

EPS is the foundation of the price-to-earnings (P/E) ratio, which is calculated by dividing the stock price by EPS. However, many cannabis companies have negative EPS because they have not yet achieved consistent profitability, making P/E ratios unusable. In these cases, investors rely on alternative metrics like P/S ratio, EV/Revenue, or adjusted EBITDA to assess valuation.

For cannabis companies that are profitable, EPS growth is a strong catalyst for stock price appreciation. Positive EPS surprises (reporting higher EPS than analysts expected) often trigger significant upward price movements, while EPS misses can lead to sharp sell-offs. Investors should track the trajectory from negative to positive EPS, as the path to profitability is a major milestone for growth-stage cannabis operators.

When analyzing earnings per share (eps) for cannabis stocks, investors must account for industry-specific factors that can distort this metric compared to other sectors. Section 280E tax treatment dramatically impacts profitability metrics for US plant-touching operators, potentially making profitable companies appear unprofitable on paper. Additionally, the rapid growth phase of the cannabis industry means that historical comparisons within the sector itself may be limited.

Cannabis companies often report both GAAP and adjusted financial figures, and earnings per share (eps) may differ significantly between the two. Investors should understand which version is being presented and what adjustments have been made. Comparing earnings per share (eps) across cannabis sub-sectors (MSOs vs. LPs vs. ancillary companies) requires additional context because each faces different regulatory environments, tax treatments, and competitive dynamics.